open access
Vol 27, No 1 (2020)
Letters to the Editor — Clinical cardiology
Submitted: 2019-12-18
Accepted: 2019-12-24
Published online: 2020-02-25
Get Citation
Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy
12
Affiliations- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China
- Shanghai Institute of Cardiovascular Diseases, Shanghai, China
open access
Vol 27, No 1 (2020)
Letters to the Editor — Clinical cardiology
Submitted: 2019-12-18
Accepted: 2019-12-24
Published online: 2020-02-25
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy
Journal
Issue
Pages
97-98
Published online
2020-02-25
Page views
4704
Article views/downloads
1614
DOI
Pubmed
Bibliographic record
Cardiol J 2020;27(1):97-98.
Authors
Junbo Ge
References (5)- Solomon SD, McMurray JJV, Anand IS, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019; 381(17): 1609–1620.
- Shah AM, Pfeffer MA. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2012; 9(10): 555–556.
- Shah SJ, Katz DH, Deo RC. Phenotypic spectrum of heart failure with preserved ejection fraction. Heart Fail Clin. 2014; 10(3): 407–418.
- Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019; 124(11): 1598–1617.
- Saiki H, Petersen IA, Scott CG, et al. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation. 2017; 135(15): 1388–1396.
